Oncology

Noavrtis teams with IBM Watson supercomputer to advance insights into breast cancer treatment.

Up to 50% of patients with HER2-positive breast cancer treated with targeted therapies develop brain metastases.

An experimental drug reactivated an enzyme to elicit tumor suppression.

Targeting PP2A enzyme shows promise treating lung cancer.

Continuous low-dose cisplatin through an implantable device could be a therapeutic option in for patients with ovarian cancer.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

Copies of the androgen receptor gene could indicate response to standard prostate cancer drugs.

Immune checkpoint inhibitors have revolutioned cancer treatment, but not all patients respond to immunotherapy.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.

Immunotherapies have improved survival in cancer patients.

Flood of new drug approvals have extended survival across cancer types.

While incidences of metastatic breast cancer are increasing, so is survival.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Leader and follower cells depend on each other for survival and invasion.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.

Ceritinib (Zykadia) approved to treat anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Expanded the indication of Zykadia includes patients with anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.

An investigational device can detect and regulate drug levels in the blood.

Imaging technology highlights cancerous features of a breast tumor.

Novartis seeks expanded indication of ceritinib (Zykadia) in the European Union.

Merkel cell polyomavirus uses protein-mediated mechanisms to remain latent.